{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:32:10Z","timestamp":1793723530741,"version":"4.6.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115756","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T18:33:15Z","timestamp":1697826795000},"page":"115756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Angiotensin-converting enzyme inhibitors and statins therapies-induced changes in omics profiles in humans and transgenic tau mice"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8887-1852","authenticated-orcid":false,"given":"Roberto","family":"Collu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4527-3227","authenticated-orcid":false,"given":"Elisa","family":"Giunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7463-3295","authenticated-orcid":false,"given":"Weiming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biopha.2023.115756_bib1","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1002\/alz.12707","article-title":"Hypertension and Alzheimer's disease pathology at autopsy: a systematic review","volume":"18","author":"Abdulrahman","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.biopha.2023.115756_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229541","article-title":"Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk","volume":"15","author":"Barthold","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2023.115756_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12881-017-0404-9","article-title":"A case report of novel mutation in PRF1 gene, which causes familial autosomal recessive hemophagocytic lymphohistiocytosis","volume":"18","author":"Bordbar","year":"2017","journal-title":"BMC Med Genet"},{"issue":"1","key":"10.1016\/j.biopha.2023.115756_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JAD-200110","article-title":"Proteomic profiling of plasma and brain tissue from Alzheimer's disease patients reveals candidate network of plasma biomarkers","volume":"76","author":"Chen","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.biopha.2023.115756_bib5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1073\/pnas.0608251104","article-title":"Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype","volume":"104","author":"Chow","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.biopha.2023.115756_bib6","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1096\/fj.11-182873","article-title":"Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease","volume":"25","author":"Dong","year":"2011","journal-title":"Faseb J."},{"issue":"9","key":"10.1016\/j.biopha.2023.115756_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098117","article-title":"Blood-based proteomic profiling identifies potential biomarker candidates and pathogenic pathways in dementia","volume":"24","author":"Ehtewish","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2023.115756_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123928","article-title":"The receptor CMRF35-Like molecule-1 (CLM-1) enhances the production of LPS-induced pro-inflammatory mediators during microglial activation","volume":"10","author":"Ejarque-Ortiz","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2023.115756_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.msard.2012.08.002","article-title":"Neural cell adhesion molecules in brain plasticity and disease","volume":"2","author":"Gnanapavan","year":"2013","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2023.115756_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-022-00523-1","article-title":"Alzheimer's disease - the journey of a healthy brain into organ failure","volume":"17","author":"Golde","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.biopha.2023.115756_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.nbd.2007.01.004","article-title":"Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease","volume":"26","author":"Hemming","year":"2007","journal-title":"Neurobiol. Dis."},{"issue":"16","key":"10.1016\/j.biopha.2023.115756_bib12","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1007\/s00018-019-03173-7","article-title":"Functions of 'A disintegrin and metalloproteases (ADAMs)' in the mammalian nervous system","volume":"76","author":"Hsia","year":"2019","journal-title":"Cell Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.biopha.2023.115756_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234632","article-title":"The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer's disease, other types of dementia and non-demented controls: A cross-sectional study","volume":"15","author":"Jonesco","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115756_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainres.2010.11.067","article-title":"Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice","volume":"1371","author":"Kurata","year":"2011","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.biopha.2023.115756_bib15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/18756190MTA4dNjE52","article-title":"The Links between Cardiovascular Diseases and Alzheimer's Disease","volume":"19","author":"Leszek","year":"2021","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115756_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13195-020-00589-3","article-title":"Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer's disease after traumatic brain injury","volume":"12","author":"Li","year":"2020","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.biopha.2023.115756_bib17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jsbmb.2019.03.003","article-title":"Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment","volume":"190","author":"Loera-Valencia","year":"2019","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115756_bib18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3233\/JAD-201039","article-title":"Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease","volume":"79","author":"Minta","year":"2021","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115756_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3233\/JAD-215410","article-title":"MSR1 and NEP are correlated with Alzheimer's disease amyloid pathology and apolipoprotein alterations","volume":"86","author":"Miron","year":"2022","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115756_bib20","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000046","article-title":"Dysfunctional ADAM22 implicated in progressive encephalopathy with cortical atrophy and epilepsy","volume":"2","author":"Muona","year":"2016","journal-title":"Neurol. Genet"},{"issue":"6","key":"10.1016\/j.biopha.2023.115756_bib21","first-page":"297","article-title":"CD200-CD200R signaling and diseases: a potential therapeutic target?","volume":"11","author":"Ngwa","year":"2019","journal-title":"Int J. Physiol. Pathophysiol. Pharm."},{"key":"10.1016\/j.biopha.2023.115756_bib22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2164-13-296","article-title":"ReadqPCR and NormqPCR: R packages for the reading, quality checking and normalisation of RT-qPCR quantification cycle (Cq) data","volume":"13","author":"Perkins","year":"2012","journal-title":"BMC Genom."},{"issue":"2","key":"10.1016\/j.biopha.2023.115756_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/1470320312459977","article-title":"Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-\u03b3 agonistic property","volume":"14","author":"Singh","year":"2013","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"8","key":"10.1016\/j.biopha.2023.115756_bib24","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/alz.12502","article-title":"Tau phosphorylation sites serine202 and serine396 are differently altered in chronic traumatic encephalopathy and Alzheimer's disease","volume":"18","author":"Stathas","year":"2022","journal-title":"Alzheimer'S. Dement.: J. Alzheimer'S. Assoc."},{"issue":"2","key":"10.1016\/j.biopha.2023.115756_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/pathophysiology28020020","article-title":"The angiotensin-converting enzyme inhibitor lisinopril mitigates memory and motor deficits in a drosophila model of Alzheimer's Disease","volume":"28","author":"Thomas","year":"2021","journal-title":"Pathophysiology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115756_bib26","article-title":"Statin therapy and risk of Alzheimer's and age-related neurodegenerative diseases","volume":"6","author":"Torrandell-Haro","year":"2020","journal-title":"Alzheimers Dement (N. Y)"},{"issue":"1","key":"10.1016\/j.biopha.2023.115756_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2008.09.003","article-title":"Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation","volume":"215","author":"Walker","year":"2009","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115756_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","article-title":"Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease","volume":"7","author":"Whelan","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2023.115756_bib29","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nm1287","article-title":"Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease","volume":"11","author":"Wu","year":"2005","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2023.115756_bib30","doi-asserted-by":"crossref","first-page":"2792884","DOI":"10.1155\/2021\/2792884","article-title":"Decreased serum NCAM levels associated with cognitive impairment in vascular dementia","volume":"2021","author":"Zhao","year":"2021","journal-title":"Dis. Markers"},{"issue":"3","key":"10.1016\/j.biopha.2023.115756_bib31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11011-016-9803-4","article-title":"Atorvastatin ameliorates cognitive impairment, A\u03b21-42 production and Tau hyperphosphorylation in APP\/PS1 transgenic mice","volume":"31","author":"Zhou","year":"2016","journal-title":"Metab. Brain Dis."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223015548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223015548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:38:50Z","timestamp":1779917930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223015548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":31,"alternative-id":["S0753332223015548"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115756","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-converting enzyme inhibitors and statins therapies-induced changes in omics profiles in humans and transgenic tau mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115756"}}